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Abstract 
Fasciculations are characterized by visible
subtle and fast contractions of muscle, even
wormlike in movement, by the contraction of a
fascicle of muscle fibers. The authors present
the case study of a 28-year-old patient with the
appearance of migratory and diffuse fascicula-
tions with an onset after partial tapering off of
oral corticosteroides (60 mg total dose) indi-
cated  for  treatment  of  Minimal  change
Glomerulopathy. Clinical Neurological physical
exam allied with an ENMG, besides other com-
plementary  laboratory  exams  were  used  for
screening  the  above-mentioned  patient.
Afterwards,  current  research  relating  to  the
topic at hand was made in order to update the
data  available  in  the  Bireme,  Scielo  and
PubMed Data Banks using the following key
words: Fasciculation’s, motor neuron disease,
and benign fasciculations in the Portuguese,
English as well as Spanish language. Although
fasciculation’s are most commonly associated
with Motor neuron disease as well as with cer-
tain  metabolic  disorders,  they  may  also  be
present  in  individuals  with  absolutely  no
underlying pathological disorders. In our case,
fasciculation potentials that have been present
for six months, with no other signs of a neuro-
genic disorder as well as absence of laboratory
findings, the patient received a diagnosis of
Benign  Fasciculation  Syndrome  (BFS).We
believe that the use of corticosteroides in high
doses with subsequent tapering contributed to
the  fasciculation’s,  especially  due  to  the
changes that this causes on the ionic chan-
nels. Fasciculation’s are symptoms seen in a
large range of conditions, and also being the
main  symptom  of  the  so-called  Benign
Fasciculation  Syndrome.  We  have  presented
an  example  of  this  clinical  syndrome  in  a
patient  whose  complaint  was  fasciculation’s,
with complete clinical remission of symptoms
following  complete  tapering  off  of  corticos-
teroid six months previously. 
Introduction 
Minimal Change Disease, formerly known
as Lipoid Nephrosis, is responsible for approx-
imately  70-90%  of  childhood  Nephrotic  syn-
drome and for 10-15% of adult nephroses.1,2
Generally speaking, it presents itself clinically
as a primary renal disease, however eventually
secondary to several other conditions such as:
Hodgkin’s disease, certain allergic states, as
well as Naiads (a situation which is known as
toxic interstitial nephritis. Treatment usually
consists  of  oral  therapy  with  corticos-
teroides.2,3
Undoubtedly,  fasciculation’s,  even  isolated
ones, are still considered to be one of the most
ominous clinical signs for the neurologist due
to their relationship with Amyotrophic Lateral
Sclerosis and other motor neuron diseases. In
view  of  this,  clinical  and  neurophysiological
reevaluation, as well as specific complementa-
ry laboratorial exams, are an integral part of
these  patients  follow  up.4 Unfortunately,
attempts at precisely outlining the true mean-
ing  of  benign  fasciculation’s hit  upon  the
absence  of  specific  neurophysiological  and
clinical  studies.  Happily,  fasciculation’s  are
also present in completely normal individuals
with no ther underlying pathologic processes
involved.4,5
Countless  adverse  side  effects  may  arise
during  corticosteroid  use,  regardless  of  the
dose. However, discontinuing the drug, even
cautiously,  is  also  potentially  hazardous
because  of  the  possible  occurrence  of  two
events:  Tapering  off  syndrome  (Abstinence)
and Secondary Adrenocortical Failure.6,7 There
is no research available in the current medical
literature that associate use of corticosteroids
with the ocurrence of BFS. Thus, the objective
of the study at hand is to present the case of a
patient who began presenting with benign fas-
ciculations  at  the  moment  of  corticosteroid
tapering,  in  this  specific  case,  methypred-
silone. 
Case Report
A 28-year-old man, medical student, reports
the onset in december of 2008, after initiating
tapering schedule for corticosteroids (methyl-
prednisolone,1  mg/kg/day),  for  treatment  of
MCGN started to present with fasciculations,
diffuse in nature, migratory and intermittently.
He says that the onset of symptoms coincided
with the tapering of corticosteroids, which was
initially at a dose of 60 mg/kg/day during 15
days, being gradually reduced to 20 mg/day on
an alternate-day schedule, unitl its complete
withdrawal in 8 weeks. He also says he had
previously experienced the same clinical pic-
ture when his fasciculatory symptoms lasted
for 3 months following abstinence. Initially, the
fasciculation’s  were  noticed  in  the  proximal
third  of  his  arm  and  the  distal  third  of  his
thigh. Later on, intrinsic muscles of the hand
and face as well as the shoulder girdle were
also involved. They would last several days em
specific  regions,  and,  subsequently,  would
spread to other more distant parts of the body.
Physical exertional activity would worsen the
fasciculations  and  would  sometimes  evolve
into painful joint/arthritic-like symptoms. 
The patient denied any type of paresis, mus-
cular atrophy or cramps. The patient was them
submitted  to a neurologic exam in December
of 2008, which revealed upon inspection, rapid,
diffuse and visible contractions in face, trunk,
upper and lower limbs. Superficial and deep
reflexes  were  normal.  No  motor  neuron
involvement  was  found.  Sensibility  was  also
normal. A CBC, electrolyte profile (potassium=
4.2  mEq/L),  (calcium=  5.1  mEq/L,  magne-
sium=  2.2  mEq/L,  phosphorus=  2.9  mEq/L)
thyroid function, viral serology, and basal corti-
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mg\dL)  and  Creatine  Kinase  (102  U\L).  The
patient  also  denied  neither  preceding  viral
event,  nor  a  bacterial  one  in  the  preceding
days or weeks. All these tests proved to be nor-
mal. No chemical poisoning signs were evident
upon  examination.  He  denied  being  a  toxic
drug  user.  He  also  denied  using  stimulant
drugs. No evidence of functional disease was
found.  He  denied  drinking  or  smoking.  He
admitted to daily ingestion of coffee, but he
denied using dietary supplements. An ENMG at
same  month,  revealed  an  interval  between
resting motor action potentials of 0.9 s. High
amplitude and duration action potentials, pos-
itive  sharp  waves,  and  fibrillation  potentials
were also found upon testing. No medication
was  prescribed.  In  May  of  2009,  after  six
months of its onset, the patient returned to the
outpatient  unit  to  inform  the  cessation  and
resolution of all symptoms. He was hence diag-
nosed with BFS and referred for follow -up. 
Discussion
Fasciculations are the result of spontaneous
discharges of motor units, although the exact
physiological  mechanism  involved  is  not  yet
known.  Fasciculation  potentials  may  even-
taully persist after distal nerve block, thus sug-
gesting axonal or even anterior horn cell dam-
age.  Experimental  studies  support  the  Idea
that the distal origino fasciculations may be
reflected in their presence among distal axon-
al ramifications (arborizations).3-5 This proba-
bly represents changes in conduction proper-
ties of ionic channels, such as fluctuations in
ionic gradients along axonal membranes. The
distinction  between  benign (no  association
with serious neurologic conditions) and malig-
nantfasciculations (commonly associated with
degenerative neurologic conditions) should be
liberally used since the most important factor
here is without a doubtless is the evaluation of
the morphology, duration, and number of phas-
es of the motor action potential as well as the
presence or absence of other types of sponta-
neous activity (acute positive waves, fibrilla-
tion potentials). It should also be noted that
there are countless clinical situations in which
fasciculations  is  a  major  chief  complaint.5
Among  several  causes  of  fasciculations,  we
may include, fasciculation’s in normal individ-
uals, as a result of neurologic disorders, asso-
ciated  with  metabolic  diseases,  medication-
induced  and  fasciculation’s  of  systemic  dis-
eases (Table 1).5,8-16 
The use of corticosteroides may lead to var-
ious manifestations such as tolerance for car-
bohydrates,  capillary  and  vascular  fragility,
proximal  myopathy,  motor  weakness,  hyper-
tension, osteoporosis, a greater susceptibility
to infections and psychiatric symptoms among
others6. It should be noted that the side effects
of the same dose of corticosteroides are vari-
able and hence heterogeneous among individ-
uals of the same population with pharmokinet-
ics and different plasmatic protein concentra-
tions  being  the  principal  reasons  for  this.7
Nevertheless, it should also be mentioned that
to the best of our knowledge now here in the
current literature has it been registered that
there  actually  exists  a  relationship  between
(BFS) and corticosteroid use, such as in our
study. A hypothetical cause and effect relation-
ship raised by our study group would be that
effects  of  corticosteroids  upon  the  hydro  -
eletrolitic balance, through changes in the cal-
cium,  sodium,  magnesium  and  potassium
channels6,7 However,  our  patient  presented
with normal values. Basal cortisol levels were
also normal.  
Attention should also be called to the fact
that  the  earliest  complaints  of  our  patient
began during the final phase of corticosteroid
tapering, with a dose of 20 mg/day on an alter-
nate-day schedule. Total tapering of time was
eight  weeks  lasted  eight,  with  the  first  two
weeks consisting of a 60 mg/day dose. In this
case, withdrawal syndrome symptoms should
also be taken into consideration. These symp-
toms  include:  anorexia,  arthralgias,  general
weakness,  weight  loss,  and  skin  exfoliation
coupled with fever.6 Unfortunately, the exact
mechanisms  through  which  the  withdrawal
syndrome occurs are still unknown. However
two main theories still are widely accepted: the
changes in plasmatic concentration of corti-
costeroides brought on by going from a higher
to a much lower dose of this drug, which will in
turn induce a clinical syndrome very similar to
Adrenal  Failure;  and  elative  glucocorticoide
resistance  leading  to  a  hypercortisolemic
state.6,7 It should also be remembered that our
patient, besides complaining of fasciculations,
also  complained  of  generalized  arthralgias.
Another question raised was the presence of
the syndromes not associated in any way with
corticosteroid  use,  such  as  neurological  dis-
eases,  medical  drugs,  intoxications/poison-
ings, metabolic and systemic diseases. 
In the case of ALS, a progressive and chron-
ic  degenerative  neurologic  disease  which
involves both upper and lower motor neuron
neurons,  seldom  present  fasciculation  at
onset.  Generally  speaking,  fasciculation’s  in
this case are associated clinically with other
signs  and  symptoms  such  as  paraparesis
among other anterior horn cell lesion symp-
toms. Such fasciculation’s in this case might
be considered as vain, unsuccessful attempts
at reinnervation on by surviving and still func-
tioning motor neurons located in partially den-
ervated muscle fibers. Although the neurologic
exam  of  our  patient  was  entirely  normal,
ENMG revealed signs of fasciculation poten-
tials, positive waves as well as fibrillations in
the various muscle groups tested.8-10
Singh et al.,4 in a study of 4 patients who
were  initially  diagnosed  with  Benign
Cramping and fasciculation Syndrome (SCFB),
identified these same patients as progressing
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Table 1. Fasciculations causes. 
1Benign fasciculations (healthy subjects)
1.1 Occasional (Mainly in Forearms, Calves and Thumb).
1.2  Caused by Coffee, Stress, Anxiety, Cigarettes.
1.3 Strenuous and high intensity exercises .
1.4 Benign fasciculations (Isolated and Persistent) - duration for months and | or years.
2Neurogenic disorders resulting from fasciculations
2.1 Amyotrophic Lateral Sclerosis.
2.2 Spinal Muscular atrophies.
2.3 Benign monomelic amyotrophy (Hirayama disease).
2.4Kennedy Disease
2.5 Multifocal Motor Neuropathy
2.6 Acute Anterior Poliomyelitis
2.7 Radiculopathy
2.8 Peripheral Neuropathies
2.9  Plexopathy
2.10 Syringomyelia
2.11Creutzfeldt-Jakob Disease
2.12 Spinal amyotrophy of upper limbs (distal)
3Fasciculations for metabolic diseases
3.1 Thyrotoxicosis
3.2 Tetanus
4 Fasciculations caused by drug use
4.1 Anticholinergic Drugs
4.2 ** Use of Steroids (corticoids)
4.3 Organophosphates and other insecticides | pesticides (commonly in the acute intoxication).
4.4  Lithium
5Fasciculations caused by systemic diseases 
5.1 Infections, mainly viral. (HIV-1, 2, HTLV-1, syphilis)
5.2 Neurosarcoidosisto  Amyotrophic  Lateral  Sclerosis.  In  view  of
this, the authors warn that a diagnosis of SCFB
should not be considered accurate without a 4
to 5 year follow up following onset of clinical
symptoms. According to the above-mentioned
considerations, a follow up of five years dura-
tion was thus requested for the proper charac-
terization of BFS in our specific case.
Mills  KR9  proposed  distinctions  between
fasciculation’s and cramps presented in ALS
and those presented in patients with BFS. This
kind of distinction was sought through the fir-
ing of motor unit fibers as well as other neuro-
physiological  parameters  and  standards.
Fasciculation potentials were recorded in 63
muscles of 28 patients with ALS and then com-
pared to 21 muscles in patients with BFS. It
should be noted that in each muscle, in a sin-
gle site/motor unit/location up to 15 fascicula-
tion potentials were identified. Thus, the char-
acteristics  of  430  fasciculation  potentials  in
patients diagnosed with ALS were compared to
the 191 benign fasciculation’s and then ana-
lyzed. Measured were the fasciculation poten-
tial itself, the area, duration and interval of fir-
ing,  variation  indexes  of  wave  morphology,
axonal conduction block testing, the variability
of axonal conduction and the potential for pro-
ducing  double  fasciculation  potentials.  The
authors concluded that the potentials found in
ALS were both shorter and of a much higher
frequency  than  those  with  BFS.  However,
although  firing  patterns  in  both  cases  were
irregular, the firing rate in the case of ALS was
shown  to  be  significantly  higher.  Whenever
muscular weakness and neurogenic alteration
were to be found on ENMG in the ALS group of
patients,  the  firing  rates  in  this  case  were
much higher, however the variability indexes
of wave form (morphology), the potential itself
as well as the amplitude of potential area were
all  significantly  reduced  in  ALS.  The  author
concluded  that  wave  form  and  fasciculation
potential morphology were not good markers
for distinguishing between benign as opposed
to  malignant  fasciculation  potentials.  Highly
complex fasciculation potentials could be iden-
tified in both instances.
Souayah et al.13 published a case study of
neurosarcoidosis  which  presented  itself  as
Lower  Motor  neuron  disease.  The  case  was
about a 43-year old male who developed pro-
gressive muscular weakness along with fascic-
ulation in all his extremities of 4 months dura-
tion. Neurologic exam was consistent with an
anterior  horn  cell  syndrome.  CSF  analysis
showed lymphocytic pleocytosis as well as an
elevated opening pressure. The diagnosis of
sarcoidosis  was  later  confirmed  through
lacrimal gland biopsy. The patient was treated
with a combination of intravenous immuno  -
globulin and corticosteroids with almost com-
plete  resolution  of  symptoms  following  dis-
charge. We have hypothesized that the granu-
lomatous  inflammatory  process  must  have
compressed  the  ventral  (motor)  root  of  the
spinal  cord,  hence  resulting  in  the  motor
symptoms. In our case, the diagnosis of neu-
rosarcoidosis was excluded. 
Fermont J et al.,14 estimated the prevalence
as well the distribution rate of fasciculation’s
among healthy adults, evaluating the effects of
age, caffeine and physical exercise. The fasci-
culation’s were studied using ultrasound in 58
healthy adults and distributed among distinct
categories  according  to  age.  Questionnaires
were used to determine the effects of caffeine
as well as exercise on the genesis of fascicula-
tion’s.  Finally, researchers tested the effects of
intense  of  physical  exercise  on  10  healthy
adults. Of the total of individuals studied, 25
(43%) presented with fasciculation’s on ultra-
sound, most of them located in the long abduc-
tor of the halux muscle. Fasciculation’s were
also identified to a lesser degree and intensity
in the middle and proximal third of the lower
limbs. The great majority of individuals who
presented with fasciculation’s were older than
those who had never complained of having fas-
ciculation’s. It was also found that caffeine and
physical activity did not play a role as far as the
prevalence  of  fasciculation’s  was  concerned.
However,  excessive,  extenuating  physical
exercise  did,  in  fact,  cause  a  temporary
increase in fasciculation’s in the lower limbs.
Our patient admitted to the use of caffeine on
a daily basis as well as to practicing regular
aerobic exercise, three times a week for about
50 minutes.
Such data were considered for the present
case at hand, since the majority of patients in
this age range made use of caffeine regularly
as well as practice physical exercise, although
this pattern and distribution of fasciculation’s
such as those found in our patient is not com-
monly seen under these conditions, which can
provoke, in rare instances, fasciculation poten-
tials, mainly in the eyelids, thumb and halux.5,6
We must keep in mind that daily exercise
possibly causes BFS through the release of a
higher  than  normal  amount  of  free  radicals
during prolonged exercise. Free radicals are a
sub  product  of  the  cell’s  energy  production;
hence, the longer the activity and the more
intense the exercise, the more free radicals
are released. For this reason, athletes are sub-
ject to an overload of free radicals as well as
oxidative stress. If prolonged exercise is actu-
ally related to benign fasciculation’s then cer-
tainly the mechanism must involve free radi-
cals that accumulate within nerve endings and
cause prolonged muscle excitability.15-16
Singh G and Khurana G17 pointed out the
effects  of  acute  organophosphate  poisoning,
one of the most common kinds of poisonings
seen in clinical emergency medicine. Among
the principal effects are those found among
the Peripheral Nervous System, which in turn
results  from  the  inactivation  of  the  acetyl
cholinesterase  enzyme  located  among  the
nicotinic as well as muscarinic receptors, not
only in the peripheral but also in the central
nervous System as well. The main neurologic
manifestations that usually occur late in the
course  of  severe  disease  are  fasciculation’s
associated  with  neuromuscular  paralysis.
Initially, however, only fasciculation’s may be
present. Our patient did not present with an
occupational history of such poisoning neither
did  he  show  any  clinical  manifestations  of
acute clinical poisoning.
We  also  considered  the  possibility  of  our
patient having made use of other medical drug
that could induce BFS, such as Lithium, for
example. Acute lithium neurotoxicity, accord-
ing  to  Azevedo  et  al.18,  manifests  itselfs
through dysarthria, ataxia and coarse tremors.
Associated with acute mental confusion, there
may also be frequent muscular fasciculations
(myofasciculations)  as  well  as  myoclonus,
with  blepharospasm  and  aparaxia  of  eyelid
opening  also  having  been  described.  These
symptoms  may  even  evovle  into  convulsive
seizures, coma and even death. Our patient did
not use any other medication besides corticos-
teroids. 
Our theory, therefore, is that he myofascicu-
lations presented by our patient may have been
related to corticosteroid use, not only through
their systemic effects, but also through their
varied effects upon polrization of ionic chan-
nels. Thus, corticosteroids, so widely used by
physicians in general as well as in diverse spe-
cialties,  have  the  potential  for  substantial
morbi-mortality within not adequately manipu-
lated.  In  view  of  this,  corticosteroids  should
always be used for the least period of time nec-
essary as to avoid unwanted side effects6. 
The treatment of benign myofasciculation is
always  symptomatic,  based  especially  upon
antiepileptic drugs, including carbamazepine,
gabapentine, and phenytoine, mostly with only
partial clinical control of symptoms. The inter-
pretation of the effect of these drugs concern-
ing their precise mechanism of action is still
speculative, although believed to be through
the decrease of distal peripheral nerve ending
excitability.5
Conclusions
Fasciculations require a meticulous clinical
and neurologic evaluation in order to look for
the  cause  behind  them.  The  diagnosis  fre-
quently is difficult to reach due to the ample
range and scope of potential clinical conditions
likely to cause them. We have presented a case
study of a patient whose chief complaint was
fasciculations,  both  diffuse  and  migratory,
with subsequent remission of symptoms with-
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teroids, which is our most likely hypothesis.
Additional  studies  will  be  necessary  in  the
future. 
References 
1. Gargah  TT,  Lakhoua  MR.  Mycophenolate
mofetil in treatment of childhood steroid-
resistant  nephrotic  syndrome.  J  Nephrol
2011;24:203-7.
2. Kari JA, El-Morshedy SM, El-Desoky S, et
al. Rituximab for refractory cases of child-
hood nephrotic syndrome. Pediatr Nephrol
2011;26:733-7. 
3. Singh  V,  Gibson  J,  McLean  B,  et  al.
Fasciculations  and  cramps:  how  benign?
Report of four cases progressing to ALS. J
Neurol 2010;258:573-8.
4. Mills KR. Characteristics of fasciculations
in  amyotrophic  lateral  sclerosis  and  the
benign  fasciculation  syndrome.  Brain
2010;133:3458-69. 
5. Buainain  RP,  Moura  LS,  Oliveira  ASB.
Fasciculação.  Rev  Neurociências  2000;8:
31-4.
6. Faiçal S, Uehara MH. Efeitos sistêmicos e
síndrome de retirada em tomadores crôni-
cos de corticosteróides. Rev Ass Med Brasil
1998;44:69-74. 
7. Pereira  ALC,  Bolzani  FCB,  Stefani  M,
Charlin  R.  Uso  sistêmico  de  corti-
costeróides:  revisão  da  literatura.  Med
Cutan Iber Lat Am 2007;35:35-50. 
8. de  Carvalho  M,  Swash  M.  Fasciculation-
cramp syndrome preceding anterior horn
cell disease: an intermediate syndrome? J
Neurol Neurosurg Psychiatry 2011;82:459-
61. 
9. Mills KR. Detecting fasciculations in amy-
otrophic  lateral  sclerosis:  duration  of
observation required. J Neurol Neurosurg
Psychiatry 2011;82:549-51. 
10. Chieia  MA,  Oliveira  ASB,  Silva  HCA,
Gabbai AA. Amyotrophic lateral sclerosis:
considerations on diagnostic criteria. Arq
Neuropsiquiatr 2010;68:837-42.
11. Orsini  M,  De  Freitas  MRG,  Nascimento
OJM,  et  al.  Atrofia  Muscular  Distal
Bilateral  dos  Membros  Superiores
(Síndrome  de  OSullivan-McLeod).  Rev
Bras Neurol 2010;46:43-35. 
12. Neves  MAO,  de  Mello  MP,  Santos  VV,
Nascimento OJM et al. Post-poliomyelitis
syndrome: case report. Arq Neuropsiquiatr
2007; 65:528-31.
13. Souayah N, Hassan AE, Krivitskaya N, et
al.  Neurosarcoidosis  presenting  as  an
anterior horn syndrome. J Neuroimmunol
2010;225:132-6.
14. Fermont  J,  Arts  IM,  Overeem  S,  et  al.
Prevalence  and  distribution  of  fascicula-
tions in healthy adults: Effect of age, caf-
feine  consumption  and  exercise.
Amyotroph Lateral Scler 2010;11:181-6.
15. Blexrud  MD,  Windebank  AJ,  Daube  JR
Long-term follow-up of 121 patients with
benign  fasciculations.  Ann  Neurol  1993;
34:622-5. 
16. Kennedy G, Spence VA, Mc Laren M, et al.
Oxidative stress levels are raised in chron-
ic  fatigue  syndrome  and  are  associated
with clinical symptoms. Free Radical Biol
Med 2005:39:584-9. 
17. Singh G, Khurana D. Neurology of acute
organophosphate poisoning. Neurol India
2009;57:119-25. 
18. Azevedo Y, Marques CA, Lacoponi E. Ataxia
prolongada  associada  à  intoxicação  por
lítio. Casos Clin Psiquiatria 2000;2:18-20. 
Case Report
[page 44] [Neurology International 2011; 3:e11]